NL-OMON39575Not yet recruitingNot Applicable
ew Oral Anticoagulants (NOAC) Study: Investigation of laboratory tests an development of a gold standard test for monitoring dabigatran and rivaroxaban therapy - NOAC study
Conditions
Trial Snapshot
- Phase
- Not Applicable
- Status
- Not yet recruiting
- Sponsor
- Catharina-ziekenhuis
- Enrollment
- 120
Study Overview
Brief Summary
No summary available.
Study Design
- Study Type
- Observational
Eligibility Criteria
- Ages
- 18 to 99 (—)
Inclusion Criteria
- •Patients using dabigatran (CZE hospital) or rivaroxaban (MMC hospital) in a profylactic dose
Exclusion Criteria
- •renal failure (GFR <30 ml/min), use of antiplatelet agents, previous malignancy, use of other oral anticoagulants (cumarins), age <18 years
Investigators
Similar Trials
Active, not recruiting
Phase 1
A study to demonstrate that a new antikoagulation therapy with apixaban is safe compared to another antikoagulation therapy with phenprocoumon in patients with chronic kidney disease and atrial fibrillation.End-Stage Kidney Disease (ESKD) on Chronic Hemodialysis Treatment and Atrial FibrillationMedDRA version: 20.0Level: PTClassification code 10003658Term: Atrial fibrillationSystem Organ Class: 10007541 - Cardiac disordersMedDRA version: 23.1Level: LLTClassification code 10076412Term: Chronic kidney disease stage 5System Organ Class: 100000004857EUCTR2015-005503-84-DEKompetenznetz Vorhofflimmern e.V.108
Active, not recruiting
Phase 1
Monitoring the effect of blood thinners during percutaneous coronary interventioAnticoagulation during percutaneous coronary interventionEUCTR2020-005298-29-NLSt. Antonius Hospital120
Recruiting
Phase 4
Monitoring the effect of oral anticoagulants during cardiac catheterisatiocoronary artery diseasepercutaneous coronary intervention10011082NL-OMON50931Sint Antonius Ziekenhuis120
Not yet recruiting
Phase 3
Investigating the effectiveness of anticoagulants compared to aspirin and clopidogrel on disease severity in patients with ischemic stroke.Cerebral infarctionIRCT20221026056307N1Bojnourd University of Medical Sciences86
Completed
Not Applicable
Assessment of Direct Oral Anticoagulant Use and Clinical Outcomes among Patients with Kidney Impairment at Faculty of Medicine Siriraj HospitalPatients who were prescribed first DOACs between January 1, 2019 to December 31, 2020Direct oral anticoagulant, dosing, kidney impairmentTCTR20230703002Faculty of Medicine Siriraj Hospital Mahidol University320